We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antigen Test Designed for Point-of-Care Detection

By LabMedica International staff writers
Posted on 14 Jun 2012
A novel antigen-detection test shows efficacy in rapidly identifying a variety of respiratory viruses at the point of care in a pediatric setting. More...


The automated, MultiAnalyte system, is capable of detecting from a single nasopharyngeal swab specimen eight respiratory viruses including respiratory syncytial virus (RSV); influenza A and B viruses; adenovirus; parainfluenza type 1, 2, and 3 viruses; and Human metapneumovirus.

Scientists at Turku University Hospital (Finland) evaluated the technology's efficacy in a pediatric emergency setting by testing samples from 158 children who had respiratory symptoms or fever, and whose mean age was 1.8 year. The samples were tested by MariPOC as well as by reverse-transcription polymerase chain reaction (RT-PCR).

Results with the MariPOC (ArcDia; Turku, Finland) test showed sensitivities and specificities for viral detection as follows: for the 36 children with RSV, 83% and 99%; for the 20 with influenza B, 85% and 96%; for the six with influenza A, 50% and 99%; for the 12 with adenovirus, 25% and 97%; and for the eight with Metapneumovirus, 50% and 100%.

Lauri Ivaska, MD, the lead author of the study said, "This test is based on fully automated random access immunoassay and delivers preliminary results in 20 minutes and final results in two hours. Approximately 70% of results are ready in 20 minutes. For these purposes we want to make the diagnosis reliable, easy and fast; however, most point-of-care tests for detection of respiratory viruses have limitations in diagnostic performance and clinical usability." Dr. Ivaska added, "The results indicate that whereas sensitivity for influenza and RSV was moderately good, sensitivity for adenovirus was low." The study was presented on May 10, 2012, at the European Society for Pediatric Infectious Diseases (ESPID) 30th Annual Meeting, held in Thessalonica (Greece).

Related Links:
Turku University Hospital
ArcDia



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.